These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1356743)

  • 1. Renal handling of alendronate in rats. An uncharacterized renal transport system.
    Lin JH; Chen IW; Deluna FA; Hichens M
    Drug Metab Dispos; 1992; 20(4):608-13. PubMed ID: 1356743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.
    Lin JH; Chen IW; deLuna FA; Hichens M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):670-5. PubMed ID: 8246140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats.
    Lin JH; Chen IW; Duggan DE
    Drug Metab Dispos; 1992; 20(4):473-8. PubMed ID: 1356720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of alendronate by bone tissue in hypocalcemic and hypercalcemic rats.
    Lin JH; Chen IW; Deluna FA
    Drug Metab Dispos; 1993; 21(5):800-4. PubMed ID: 7902239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of alendronate: an overview.
    Lin JH; Russell G; Gertz B
    Int J Clin Pract Suppl; 1999 Apr; 101():18-26. PubMed ID: 12669737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear kinetics of alendronate. Plasma protein binding and bone uptake.
    Lin JH; Chen IW; deLuna FA
    Drug Metab Dispos; 1994; 22(3):400-5. PubMed ID: 8070316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals.
    Lin JH; Duggan DE; Chen IW; Ellsworth RL
    Drug Metab Dispos; 1991; 19(5):926-32. PubMed ID: 1686238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats.
    Lin JH; Chen IW; Ulm EH; Duggan DE
    Drug Metab Dispos; 1988; 16(3):392-6. PubMed ID: 2900730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal handling of drugs in renal failure. I: Differential effects of uranyl nitrate- and glycerol-induced acute renal failure on renal excretion of TEAB and PAH in rats.
    Lin JH; Lin TH
    J Pharmacol Exp Ther; 1988 Sep; 246(3):896-901. PubMed ID: 3418518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic studies on the competition between famotidine and cimetidine in rats. Evidence of multiple renal secretory systems for organic cations.
    Lin JH; Los LE; Ulm EH; Duggan DE
    Drug Metab Dispos; 1988; 16(1):52-6. PubMed ID: 2894955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion kinetics of famotidine in rats.
    Lin JH; Los LE; Ulm EH; Duggan DE
    Drug Metab Dispos; 1987; 15(2):212-6. PubMed ID: 2882981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of p-aminohippurate, tetraethylammonium and D-glucose in renal brush border membranes from rats with acute renal failure.
    Hori R; Takano M; Okano T; Inui K
    J Pharmacol Exp Ther; 1985 Jun; 233(3):776-81. PubMed ID: 2989496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.
    Aiba T; Sakurai Y; Tsukada S; Koizumi T
    J Pharmacol Exp Ther; 1995 Jan; 272(1):94-9. PubMed ID: 7815370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate.
    Kanatsu K; Aihara E; Okayama M; Kato S; Takeuchi K
    J Gastroenterol Hepatol; 2004 May; 19(5):512-20. PubMed ID: 15086594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of organ perfusion on renal drug transport. Application to furosemide in the isolated perfused rat kidney.
    Lee LJ; Smith DE
    Drug Metab Dispos; 1989; 17(1):32-6. PubMed ID: 2566466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney.
    Muirhead MR; Somogyi AA
    Drug Metab Dispos; 1991; 19(2):312-6. PubMed ID: 1676629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiallodynic effect of etidronate, a bisphosphonate, in rats with adjuvant-induced arthritis: involvement of ATP-sensitive K+ channels.
    Kawabata A; Kawao N; Hironaka Y; Ishiki T; Matsunami M; Sekiguchi F
    Neuropharmacology; 2006 Aug; 51(2):182-90. PubMed ID: 16678221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal excretion and distribution of ceftizoxime in rats.
    Terakawa M; Tsuchiya T; Watanabe Y; Noguchi H
    J Pharmacol Exp Ther; 1981 Apr; 217(1):209-14. PubMed ID: 6937652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal handling of enalapril and enalaprilat: studies in the isolated red blood cell-perfused rat kidney.
    de Lannoy IA; Nespeca R; Pang KS
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1211-22. PubMed ID: 2557416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of risedronate, alendronate, and etidronate on the viability and activity of rat bone marrow stromal cells in vitro.
    Still K; Phipps RJ; Scutt A
    Calcif Tissue Int; 2003 Feb; 72(2):143-50. PubMed ID: 12457261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.